Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression

Overview of attention for article published in Science Advances, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

blogs: 1 blog

twitter: 8 X users

Readers on

mendeley: 52 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 47,869 followers.

RT @celltherapynews: New work in @ScienceAdvances shows engineered PD-L1 and cytotoxic T lymphocyte antigen 4 immunoglobulin fusion protein…

RT @MesenchymalCell: Led by Dr. Minglin Ma, @Cornell collaborators engineered programmed death ligand-1 and cytotoxic T lymphocyte antigen…

New work in @ScienceAdvances shows engineered PD-L1 and cytotoxic T lymphocyte antigen 4 immunoglobulin fusion protein–modified #mesenchymal stromal cells as accessory cells for #islet #cotransplantation. 🧫 Learn more: 📌 https://t.co/D3JPANuImG https:/…

RT @MesenchymalCell: Led by Dr. Minglin Ma, @Cornell collaborators engineered programmed death ligand-1 and cytotoxic T lymphocyte antigen…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.